Harpoon Therapeutics, Inc. (HARP) Net earnings per share growth forecast for next year

Symbol and logo of brand Harpoon Tx (HARP)

Harpoon Therapeutics (HARP) confirmed its expertise in T-cell therapy through a deal with Merck. High R&D costs and strict regulatory oversight create significant barriers to entry. The forward earnings per share growth forecast reflects analyst expectations, with the indicator level standing at -173.10. Meanwhile, the company effectively utilizes third-party testing centers while maintaining full control over its patents.

HARP - Harpoon Tx Earnings growth forecast for next year over the range 07/04/2022 - 03/16/2024

Metric breakdowns and analytics for Harpoon Tx (HARP)

- price and consensus price forecast:
Analysis of all company metrics:Harpoon Tx
Core merchandise of Harpoon Therapeutics Inc

Harpoon Therapeutics (HARP) specialized in the development of T-cell immunotherapeutic platforms, although pre-commercial stage risks were mitigated through a merger with a pharmaceutical behemoth. By analyzing the history of forward earnings per share valuations, an investor tracks the dynamics of consensus EPS forecasts, which allows for the timely identification of shifts in market expectations and the avoidance of purchasing overvalued assets at the peak of analyst optimism.

Direct competitors

Net earnings per share growth forecast for next year immunitybio.com|Expected earnings per share growth for next year immunocore.com (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics Inc (JANX)|Expected earnings per share growth for next year Arcus Bio RCUS|Zymeworks Inc - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Corp TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (immatics.com) - Projected earnings per share growth rate for next year|Xencor Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Compass Bio (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen Ltd.)|Expected earnings per share trend next year IOBT|sutrobio.com - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics, Inc|Werewolf (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma Inc. - Expected earnings per share trend next year|ALXO (alxoncology.com) - Earnings growth forecast for next year|Cue Biopharma, Inc. - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year pdsbiotech.com (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotech - Expected earnings per share growth for next year|liminatuspharma.com (LIMN) - Expected net earnings per share growth next year|LVTX - Net earnings per share growth forecast for next year|NXTC (NextCure) - Projected earnings per share growth rate for next year|LPTX: Earnings growth forecast for next year|Projected earnings per share growth rate for next year INTS|Net earnings per share growth forecast for next year Sensei Biotherapeutics, Inc.|Expected net earnings per share growth next year therivabio.com TOVX|Expected earnings per share growth for next year GRTS (Gritstone bio, Inc.)|Earnings growth forecast for next year Kineta Bio (KA)|Net earnings per share growth forecast for next year NexImmune Corporation NEXI|Consensus forecast of earnings per share growth for next year turnstonebio.com (TSBX)|VCNX - Net earnings per share growth forecast for next year